MarketAnalysisMarketAnalysis
NYSE:MDT

Medtronic plc - NYSE:MDT - Comprehensive analysis

Free evaluation through quantitative algorithms Medtronic plc - NYSE:MDT

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

2.72

Market

41

Sector

51

Gross Profit Growth Over Prior Year

2.49

Market

31

Sector

48

EBITDA Growth Over Prior Year

5.16

Market

44

Sector

53

EBITA Growth Over Prior Year

5.31

Market

48

Sector

46

EBIT Growth Over Prior Year

7.28

Market

50

Sector

49

Earnings from Cont. Ops. Growth Over Prior Year

1.32

Market

42

Sector

41

Net Income Growth Over Prior Year

1.4

Market

42

Sector

43

Normalized Net Income Growth Over Prior Year

-1.18

Market

32

Sector

27

Diluted EPS before Extra Growth Over Prior Year

3.82

Market

44

Sector

45

A/R Growth Over Prior Year

2.46

Market

52

Sector

62

Inventory Growth Over Prior Year

-2.03

Market

27

Sector

21

PPE Net Growth Over Prior Year

12.93

Market

84

Sector

79

Total Assets Growth Over Prior Year

-0.95

Market

29

Sector

46

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

-4.64

Market

20

Sector

49

Cash from Ops. Growth Over Prior Year

12.72

Market

67

Sector

54

CAPEX Growth Over Prior Year

18.65

Market

75

Sector

76

Dividend per Share Growth Over Prior Year

1.45

Market

40

Sector

95

Levered Free Cash Flow Growth Over Prior Year

-4.06

Market

34

Sector

31

Unlevered Free Cash Flow Growth Over Prior Year

-3.18

Market

35

Sector

30

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

66

Market

81

Sector

66

SG&A Margin %

31

Market

83

Sector

43

EBITDA Margin %

28.6

Market

60

Sector

91

EBITA Margin %

25.6

Market

71

Sector

90

EBIT Margin %

20.6

Market

58

Sector

91

Earnings from Cont. Ops Margin %

12.92

Market

51

Sector

90

Net Income Margin %

12.83

Market

50

Sector

90

Net Income Avail. for Common Margin %

12.83

Market

51

Sector

90

Normalized Net Income Margin %

12.31

Market

63

Sector

91

Levered Free Cash Flow Margin %

15.44

Market

67

Sector

87

Unlevered Free Cash Flow Margin %

16.86

Market

66

Sector

87

Return on Assets %

4.72

Market

46

Sector

83

Return on Capital %

5.56

Market

35

Sector

81

Return on Equity %

8.44

Market

23

Sector

83

Return on Common Equity %

8.42

Market

22

Sector

83

Total Asset Turnover

0.37

Market

34

Sector

52

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 50
Momentum: 55
Growth: 44
Profitability: 54

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

3.79

Market

53

Sector

57

TEV/LTM EBITDA

12.98

Market

48

Sector

74

P/LTM Normalized EPS

29.6

Market

51

Sector

54

P/BV

2.24

Market

34

Sector

58

TEV/LTM Unlevered FCF

22.7

Market

42

Sector

72

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-9.51

Market

26

Sector

61

3M Price Performance

2.97

Market

72

Sector

84

6M Price Performance

-5.21

Market

56

Sector

72

9M Price Performance

8.04

Market

70

Sector

82

1Y Price Performance

2.49

Market

51

Sector

79

Start analyzing Medtronic plc - NYSE:MDT with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports